Print

Purpose

The purpose of this study is to develop a prospective cohort of patients with and without cardiac sarcoidosis as well as active and inactive disease to develop a prospective biobank from which exosome analysis of peripheral blood will derive unique biomarkers of disease activity in cardiac sarcoidosis.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults ≥18 years. - Patients referred to the Cardiac Sarcoid Clinic with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis. - Undergoing FDG-PET as part of standard care. - Ability to provide informed consent.

Exclusion Criteria

• Inability to provide informed consent.

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Cardiac Sarcoidosis Patients Patients with a clinical suspicion or a previously confirmed diagnosis of cardiac sarcoidosis.
  • Other: Exosome Analysis
    Blood Samples will undergo exosome profiling using mass spectrometry and/or other discovery-based approaches

Recruiting Locations

Mayo Clinic in Rochester
Rochester, Minnesota 55905
Contact:
Anna Pick
507-255-0630
pick.anna@mayo.edu

More Details

Status
Recruiting
Sponsor
Mayo Clinic

Study Contact

Anna Pick
507-255-0630
pick.anna@mayo.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.